Shares of bitcoin miner Core Scientific (CORZ) have been downgraded to impartial from purchase by dealer H.C. Wainwright, which cited heightened threat publicity following the corporate’s recently announced deal with AI cloud supplier CoreWeave (CRWV).
The brokerage eliminated its worth goal on the inventory, noting that Core Scientific’s efficiency is now extra tightly linked to CoreWeave’s trajectory.
Core Scientific shares have been 1.3% greater at publication time, buying and selling round $15. The inventory fell 18% yesterday following information of the deal. CoreWeave was 2.6% decrease.
AI infrastructure agency CoreWeave stated Monday it agreed to buy Core Scientific in an all-stock transaction valuing the bitcoin miner at about $20.40 per share, based mostly on current closing costs.
Whereas the dealer continues to view its personal Core Scientific gross sales estimates as conservative, significantly because it hasn’t factored in subsequent 12 months’s deliberate HPC (high-performance computing) buildout, it flagged a number of unresolved variables, together with excellent infrastructure procurement.
Nonetheless, the agency’s analysts anticipate shareholder approval for the transaction, with no indication of delays within the closing timeline.
H.C. Wainwright characterised Core Scientific as carrying “the inherent high-risk ranges of cryptocurrency corporations,” citing community hashrate volatility and crypto market fluctuations.
Whereas Core’s diversified operations assist offset a few of that threat in contrast with smaller friends, the corporate now additionally takes on publicity to CoreWeave’s AI adoption dangers, buyer focus and leverage, the report stated.
Further headwinds embrace potential dilution, mining gear shortages, rising regulatory scrutiny and operational hurdles.
On a extra constructive notice, the anticipated contribution of HPC revenues in future quarters may assist cut back the corporate’s sensitivity to bitcoin worth cycles and stabilize outcomes, the report added.
Learn extra: CoreWeave’s All-Stock Bid for Core Scientific Likely to Draw Shareholder Scrutiny: KBW